These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 7811279

  • 1. Unusual insulin binding to cells expressing an insulin receptor mutated at cysteine 524.
    Bilan PJ, Yip CC.
    Biochem Biophys Res Commun; 1994 Dec 30; 205(3):1891-8. PubMed ID: 7811279
    [Abstract] [Full Text] [Related]

  • 2. Leu 193 mutation in the cysteine rich region of the insulin receptor inhibits the cleavage of the insulin receptor precursor but not insulin binding.
    Takata Y, Imamura T, Haruta T, Egawa K, Takada Y, Sawa T, Yang GH, Kobayashi M.
    Biochem Biophys Res Commun; 1994 Sep 15; 203(2):763-7. PubMed ID: 8093054
    [Abstract] [Full Text] [Related]

  • 3. Cysteine residues are involved in structure and function of melanocortin 1 receptor: Substitution of a cysteine residue in transmembrane segment two converts an agonist to antagonist.
    Frändberg PA, Doufexis M, Kapas S, Chhajlani V.
    Biochem Biophys Res Commun; 2001 Mar 09; 281(4):851-7. PubMed ID: 11237737
    [Abstract] [Full Text] [Related]

  • 4. An arginine to cysteine(252) mutation in insulin receptors from a patient with severe insulin resistance inhibits receptor internalisation but preserves signalling events.
    Hamer I, Foti M, Emkey R, Cordier-Bussat M, Philippe J, De Meyts P, Maeder C, Kahn CR, Carpentier JL.
    Diabetologia; 2002 May 09; 45(5):657-67. PubMed ID: 12107746
    [Abstract] [Full Text] [Related]

  • 5. Mutational analysis of the N-linked glycosylation sites of the human insulin receptor.
    Elleman TC, Frenkel MJ, Hoyne PA, McKern NM, Cosgrove L, Hewish DR, Jachno KM, Bentley JD, Sankovich SE, Ward CW.
    Biochem J; 2000 May 01; 347 Pt 3(Pt 3):771-9. PubMed ID: 10769182
    [Abstract] [Full Text] [Related]

  • 6. Effects of cysteine to serine substitutions in the two inter-chain disulfide bonds of insulin.
    Guo ZY, Feng YM.
    Biol Chem; 2001 Mar 01; 382(3):443-8. PubMed ID: 11347892
    [Abstract] [Full Text] [Related]

  • 7. Intra-A chain disulfide bond (A6-11) of insulin is essential for displaying its activity.
    Dai Y, Tang JG.
    Biochem Mol Biol Int; 1994 Aug 01; 33(6):1049-53. PubMed ID: 7804129
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Increased levels of insulin and insulin-like growth factor-1 hybrid receptors and decreased glycosylation of the insulin receptor alpha- and beta-subunits in scrapie-infected neuroblastoma N2a cells.
    Nielsen D, Gyllberg H, Ostlund P, Bergman T, Bedecs K.
    Biochem J; 2004 Jun 01; 380(Pt 2):571-9. PubMed ID: 15025560
    [Abstract] [Full Text] [Related]

  • 10. Characterization of a second ligand binding site of the insulin receptor.
    Hao C, Whittaker L, Whittaker J.
    Biochem Biophys Res Commun; 2006 Aug 18; 347(1):334-9. PubMed ID: 16814253
    [Abstract] [Full Text] [Related]

  • 11. Disulfide reduction converts the insulin receptor of human placenta to a low affinity form.
    Jacobs S, Cuatrecasas P.
    J Clin Invest; 1980 Dec 18; 66(6):1424-7. PubMed ID: 7440724
    [Abstract] [Full Text] [Related]

  • 12. Role of acidic amino acids in the allosteric modulation by gallamine of antagonist binding at the m2 muscarinic acetylcholine receptor.
    Leppik RA, Miller RC, Eck M, Paquet JL.
    Mol Pharmacol; 1994 May 18; 45(5):983-90. PubMed ID: 8190113
    [Abstract] [Full Text] [Related]

  • 13. Cysteine 647 in the insulin receptor is required for normal covalent interaction between alpha- and beta-subunits and signal transduction.
    Cheatham B, Kahn CR.
    J Biol Chem; 1992 Apr 05; 267(10):7108-15. PubMed ID: 1551916
    [Abstract] [Full Text] [Related]

  • 14. Kinetic evidence for the sequential association of insulin binding sites 1 and 2 to the insulin receptor and the influence of receptor isoform.
    Thorsøe KS, Schlein M, Steensgaard DB, Brandt J, Schluckebier G, Naver H.
    Biochemistry; 2010 Jul 27; 49(29):6234-46. PubMed ID: 20568733
    [Abstract] [Full Text] [Related]

  • 15. Altered ligand dissociation rates in thyrotropin-releasing hormone receptors mutated in glutamine 105 of transmembrane helix III.
    del Camino D, Barros F, Pardo LA, de la Peña P.
    Biochemistry; 1997 Mar 18; 36(11):3308-18. PubMed ID: 9116009
    [Abstract] [Full Text] [Related]

  • 16. Ligand-binding characteristics and related structural features of the expressed goldfish kainate receptors: identification of a conserved disulfide bond and three residues important for ligand binding.
    Wo ZG, Oswald RE.
    Mol Pharmacol; 1996 Oct 18; 50(4):770-80. PubMed ID: 8863821
    [Abstract] [Full Text] [Related]

  • 17. Insulin receptor binding kinetics: modeling and simulation studies.
    Wanant S, Quon MJ.
    J Theor Biol; 2000 Aug 07; 205(3):355-64. PubMed ID: 10882558
    [Abstract] [Full Text] [Related]

  • 18. Cys 786 and Cys 776 in the posttranslational processing of the insulin and IGF-I receptors.
    Maggi D, Cordera R.
    Biochem Biophys Res Commun; 2001 Jan 26; 280(3):836-41. PubMed ID: 11162597
    [Abstract] [Full Text] [Related]

  • 19. Replacement of the conserved tyrosine 1210 by phenylalanine in the insulin receptor affects insulin-induced dephosphorylation of focal adhesion kinase but leaves other responses intact.
    Van der Zon GC, Ouwens DM, Dorrestijn J, Maassen JA.
    Biochemistry; 1996 Aug 13; 35(32):10377-82. PubMed ID: 8756693
    [Abstract] [Full Text] [Related]

  • 20. In vitro phosphorylation of insulin receptor substrate 1 by protein kinase C-zeta: functional analysis and identification of novel phosphorylation sites.
    Sommerfeld MR, Metzger S, Stosik M, Tennagels N, Eckel J.
    Biochemistry; 2004 May 18; 43(19):5888-901. PubMed ID: 15134463
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.